Methods : Four children between three and five years of age received eight-weekly physical therapy sessions incorporating hippotherapy. Outcome measures included the Gross Motor Function Measure-88 (GMFM-88), parental perception of function during every day activities, spatiotemporal parameters of gait ...
Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent disorders in children and adolescents. Neurofeedback, a nonpharmaceutical treatment, has shown promising results. To review the evidence of efficacy of neurofeedback as a treatment for children and adolescents with ADHD. A ...
Main Outcome Measures Five principal components were extracted from the 24-item HDRS for all subjects and ProMax rotated: psychic depression, loss of motivated behavior, psychosis, anxiety, and sleep disturbance. The [18F]-FDG scans were acquired in a subgroup of 43 drug-free patients in twelve...
Given the reported beneficial effects of agonists in these systems on motor learning and sensorimotor outcome after cerebral stroke (see below), one might have expected that CAB, MPH, and TAC had resulted in enhancing effects on PAS-induced LTP-like plasticity. However, a critical apprai- sal ...
The sample size for this trial was estimated on the basis of comparison of neuroEPO plus and placebo with respect to the primary efficacy outcome, the change from baseline at 48 weeks in the ADAS-Cog11 score. A reduction of at least 3 points between the changes of the ADAS-Cog11 total ...
Year(s) and location of infectionAge, sexNeuroinvasionNeurotropismNeurovirulenceOutcomeRefs CNS lesionsNeurological symptoms 1997 – Hong Kong 13F No – Yes Yes Fa [154,155] 25F –e Fa 24F – R 2003/2004 – Thailand 6M Yes – Yesa No Fa [156,157] 2004 – Vietnam 4M Yes – – Yes ...
Secondary outcome measures Functional mobility and postural stability For the overall ATE on TUG, negligible differences were found between Groups A-C and Group D (Group B: ATE = -0.37 s [-1.57, 0.83], t(35) = -0.58, p = 0.57; Group A: ATE = 0.3 s [-0.92, 1.53], t(...
The DHI and all other outcome measures were obtained immediately before and after the rehabilitation training period, as well as 3 and 12 months later. One secondary outcome measure was the SBDT/gSBDT composite score recorded without any feedback signal. The SBDT/gSBDT composite score, a risk...
2.3. Outcome Measures The primary outcome measure was patient usability and satisfaction with the innovative treatments, assessed using the System Usability Scale (SUS) [26]. Additionally, the Goal Attainment Scaling (GAS) [27] was used to measure patients’ perception of goal achievement, while th...
Surface correlation between the Target and therapy spatiotemporal spinal maps are shown on Fig. 5d. d, Bar plots show measures of gait quality, efficacy and symmetry, as well as balance: participants walk score (number of trials: DBSOFF - EESOFF: 2; DBSON - EESOFF: 2; DBSOFF - EESON...